Topics:
Pulmonology • Diffuse Parenchymal Lung Disease
Do you perform routine interval screening for pulmonary fibrosis in individuals who have been identified through genetic testing as being at risk for developing pulmonary fibrosis but don't exhibit any signs or symptoms?
Specifically considering individuals with known mutations in MUC5B, TERT/TERC, etc